Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer

被引:31
|
作者
Feng, Yusen [1 ]
Liu, Hui [1 ]
Ding, Yingying [2 ]
Zhang, Ya [2 ]
Liao, Chengde [2 ]
Jin, Yan [2 ]
Ai, Conghui [2 ]
机构
[1] Kunming Yanan Hosp, Dept Radiol, Key Lab Tumor Immunol Prevent & Treatment Yunnan, Kunming, Yunnan, Peoples R China
[2] Kunming Med Univ, Dept Radiol, Affiliated Hosp 3, 519 Kunzhou Rd, Kunming 650031, Yunnan, Peoples R China
来源
TUMORI JOURNAL | 2020年 / 106卷 / 02期
关键词
Uterine cervical neoplasms; magnetic resonance imaging; diffusion magnetic resonance imaging; neoadjuvant chemotherapy; functional MRI; EARLY RESPONSE; CHEMORADIATION; RADIOTHERAPY; CARCINOMA; EFFICACY; THERAPY; TUMOR;
D O I
10.1177/0300891619886656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To prospectively investigate changes in quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and the apparent diffusion coefficient (ADC) of diffusion-weighted imaging (DWI) in patients with cervical cancer before and after neoadjuvant chemotherapy (NACT). Methods: Thirty-eight patients with cervical cancer underwent DCE-MRI and DWI 1 week before and 4 weeks after NACT. The patients were classified into 2 groups: significant reaction (sCR) group and the non-sCR group. DCE-MRI parameters and ADC values were measured and compared between the 2 groups. Results: Before NACT, the mean K-trans value was higher, but the mean V-e was lower, in the sCR group compared with the non-sCR group; these differences were statistically significant (p<0.05). After NACT, the mean K-trans value and the delta (i.e., changed) value of K-trans were significantly lower in the sCR group compared with the non-sCR group (p<0.05). However, the mean ADC and the delta value of the mean ADC between the 2 groups were slightly higher in the sCR group compared with the non-sCR group (p<0.05). The area under the curve of pre-mean K-trans, DKtrans, and pre-mean K-trans combined with post-mean ADC values were 0.801, 0.955, and 0.878, respectively (p<0.05). The optimal cutoff values for distinguishing sCR from non-sCR were pretreatment K-trans (0.7020 min(-1)) and DKtrans (0.0437 min(-1)). Conclusions: Quantitative parameters (pre-mean K-trans, DKtrans, and pre-mean K-trans) combined with post-mean ADC could predict treatment efficacy more precisely. However, quantitative DCE-MRI combined with DWI could not significantly improve prognostic efficacy.
引用
下载
收藏
页码:155 / 164
页数:10
相关论文
共 50 条
  • [31] Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy
    Liu, Shangang
    Ren, Ruimei
    Chen, Zhaoqiu
    Wang, Yongsheng
    Fan, Tingyong
    Li, Chengli
    Zhang, Pinliang
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2015, 42 (03) : 779 - 787
  • [32] Diffusion-weighted MRI and histogram analysis: assessment of response to neoadjuvant chemotherapy in nephroblastoma
    Andreas M. Hötker
    Yousef Mazaheri
    André Lollert
    Jens-Peter Schenk
    Junting Zheng
    Marinela Capanu
    Oguz Akin
    Norbert Graf
    Gundula Staatz
    Abdominal Radiology, 2021, 46 : 3317 - 3325
  • [33] Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Park, Sang Hee
    Moon, Woo Kyung
    Cho, Nariya
    Song, In Chan
    Chang, Jung Min
    Park, In-Ae
    Han, Wonshik
    Noh, Dong-Young
    RADIOLOGY, 2010, 257 (01) : 56 - 63
  • [34] Diffusion-weighted MRI and histogram analysis: assessment of response to neoadjuvant chemotherapy in nephroblastoma
    Hotker, Andreas M.
    Mazaheri, Yousef
    Lollert, Andre
    Schenk, Jens-Peter
    Zheng, Junting
    Capanu, Marinela
    Akin, Oguz
    Graf, Norbert
    Staatz, Gundula
    ABDOMINAL RADIOLOGY, 2021, 46 (07) : 3317 - 3325
  • [35] Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging
    Xu, H. D.
    Zhang, Y. Q.
    NEOPLASMA, 2017, 64 (03) : 430 - 436
  • [36] Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation
    Liu, Y.
    Bai, R.
    Sun, H.
    Liu, H.
    Zhao, X.
    Li, Y.
    CLINICAL RADIOLOGY, 2009, 64 (11) : 1067 - 1074
  • [37] Is it possible to predict the radiosensitivity of cervical cancer using dynamic contrast enhanced MRI (DCE-MRI)?
    Szluha, Lazanyi K.
    Pintye, E.
    Benko, K.
    Der, A.
    Poka, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 48 - 48
  • [38] Diffusion-weighted MRI for the prediction of response to neoadjuvant chemoradiotherapy in esophageal cancer
    Van Rossum, P. S. N.
    Van Lier, A. L. H.
    Van Vulpen, M.
    Reerink, O.
    Lin, S. H.
    Van Hillegersberg, R.
    Ruurda, J. P.
    Meijer, G. J.
    Lips, I. M.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S302 - S303
  • [39] Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study
    Thawani, Rajat
    Gao, Lina
    Mohinani, Ajay
    Tudorica, Alina
    Li, Xin
    Mitri, Zahi
    Huang, Wei
    BMC MEDICAL IMAGING, 2022, 22 (01)